Bayer Announces Advancement in Cardiovascular Health Assessment With Saudi Heart Association's Recent Publication on Early Detection of Subclinical Atherosclerosis in Clinical Practice
June 09, 2026
June 09, 2026
LEVERKUSEN, Germany, June 9 -- Bayer, a pharmaceutical and life sciences company, issued the following news release:
* * *
Bayer Announces Advancement in Cardiovascular Health Assessment with Saudi Heart Association's recent publication on Early Detection of Subclinical Atherosclerosis in Clinical Practice
Basel, Switzerland - Bayer, a global leader in consumer health, is proud to announce an important milestone in its ongoing commitment to enhancing c . . .
* * *
Bayer Announces Advancement in Cardiovascular Health Assessment with Saudi Heart Association's recent publication on Early Detection of Subclinical Atherosclerosis in Clinical Practice
Basel, Switzerland - Bayer, a global leader in consumer health, is proud to announce an important milestone in its ongoing commitment to enhancing c . . .
